Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 69

1.

Meta-analysis of human lung cancer microRNA expression profiling studies comparing cancer tissues with normal tissues.

Guan P, Yin Z, Li X, Wu W, Zhou B.

J Exp Clin Cancer Res. 2012 Jun 6;31:54. doi: 10.1186/1756-9966-31-54.

2.

Common patterns and disease-related signatures in tuberculosis and sarcoidosis.

Maertzdorf J, Weiner J 3rd, Mollenkopf HJ; TBornotTB Network., Bauer T, Prasse A, Müller-Quernheim J, Kaufmann SH.

Proc Natl Acad Sci U S A. 2012 May 15;109(20):7853-8. doi: 10.1073/pnas.1121072109. Epub 2012 Apr 30.

3.

Diagnosis of pancreatic ductal adenocarcinoma and chronic pancreatitis by measurement of microRNA abundance in blood and tissue.

Bauer AS, Keller A, Costello E, Greenhalf W, Bier M, Borries A, Beier M, Neoptolemos J, Büchler M, Werner J, Giese N, Hoheisel JD.

PLoS One. 2012;7(4):e34151. doi: 10.1371/journal.pone.0034151. Epub 2012 Apr 12.

4.

MicroRNAs miR-144/144* and miR-16 in peripheral blood are potential biomarkers for naturalistic stress in healthy Japanese medical students.

Katsuura S, Kuwano Y, Yamagishi N, Kurokawa K, Kajita K, Akaike Y, Nishida K, Masuda K, Tanahashi T, Rokutan K.

Neurosci Lett. 2012 May 10;516(1):79-84. doi: 10.1016/j.neulet.2012.03.062. Epub 2012 Mar 30.

PMID:
22484483
5.

Serum microRNA biomarkers for detection of non-small cell lung cancer.

Hennessey PT, Sanford T, Choudhary A, Mydlarz WW, Brown D, Adai AT, Ochs MF, Ahrendt SA, Mambo E, Califano JA.

PLoS One. 2012;7(2):e32307. doi: 10.1371/journal.pone.0032307. Epub 2012 Feb 28.

6.

Secreted microRNAs: a new form of intercellular communication.

Chen X, Liang H, Zhang J, Zen K, Zhang CY.

Trends Cell Biol. 2012 Mar;22(3):125-32. doi: 10.1016/j.tcb.2011.12.001. Epub 2012 Jan 17.

PMID:
22260888
7.

Circulating micro-RNAs as potential blood-based markers for early stage breast cancer detection.

Schrauder MG, Strick R, Schulz-Wendtland R, Strissel PL, Kahmann L, Loehberg CR, Lux MP, Jud SM, Hartmann A, Hein A, Bayer CM, Bani MR, Richter S, Adamietz BR, Wenkel E, Rauh C, Beckmann MW, Fasching PA.

PLoS One. 2012;7(1):e29770. doi: 10.1371/journal.pone.0029770. Epub 2012 Jan 5.

8.

Blood cell origin of circulating microRNAs: a cautionary note for cancer biomarker studies.

Pritchard CC, Kroh E, Wood B, Arroyo JD, Dougherty KJ, Miyaji MM, Tait JF, Tewari M.

Cancer Prev Res (Phila). 2012 Mar;5(3):492-7. doi: 10.1158/1940-6207.CAPR-11-0370. Epub 2011 Dec 12.

9.

MicroRNA modulation in complex regional pain syndrome.

Orlova IA, Alexander GM, Qureshi RA, Sacan A, Graziano A, Barrett JE, Schwartzman RJ, Ajit SK.

J Transl Med. 2011 Nov 10;9:195. doi: 10.1186/1479-5876-9-195.

10.

Next-generation sequencing identifies novel microRNAs in peripheral blood of lung cancer patients.

Keller A, Backes C, Leidinger P, Kefer N, Boisguerin V, Barbacioru C, Vogel B, Matzas M, Huwer H, Katus HA, Stähler C, Meder B, Meese E.

Mol Biosyst. 2011 Dec;7(12):3187-99. doi: 10.1039/c1mb05353a. Epub 2011 Oct 25.

PMID:
22027949
11.

MicroRNAs in renal cell carcinoma: diagnostic implications of serum miR-1233 levels.

Wulfken LM, Moritz R, Ohlmann C, Holdenrieder S, Jung V, Becker F, Herrmann E, Walgenbach-Brünagel G, von Ruecker A, Müller SC, Ellinger J.

PLoS One. 2011;6(9):e25787. doi: 10.1371/journal.pone.0025787. Epub 2011 Sep 30.

12.

Decision making in patients with pulmonary nodules.

Ost DE, Gould MK.

Am J Respir Crit Care Med. 2012 Feb 15;185(4):363-72. doi: 10.1164/rccm.201104-0679CI. Epub 2011 Oct 6. Review.

13.

Haemolysis during sample preparation alters microRNA content of plasma.

Kirschner MB, Kao SC, Edelman JJ, Armstrong NJ, Vallely MP, van Zandwijk N, Reid G.

PLoS One. 2011;6(9):e24145. doi: 10.1371/journal.pone.0024145. Epub 2011 Sep 1.

14.

Plasma microRNAs as novel biomarkers for early detection of lung cancer.

Zheng D, Haddadin S, Wang Y, Gu LQ, Perry MC, Freter CE, Wang MX.

Int J Clin Exp Pathol. 2011 Aug 15;4(6):575-86. Epub 2011 Aug 8.

15.

Toward the blood-borne miRNome of human diseases.

Keller A, Leidinger P, Bauer A, Elsharawy A, Haas J, Backes C, Wendschlag A, Giese N, Tjaden C, Ott K, Werner J, Hackert T, Ruprecht K, Huwer H, Huebers J, Jacobs G, Rosenstiel P, Dommisch H, Schaefer A, Müller-Quernheim J, Wullich B, Keck B, Graf N, Reichrath J, Vogel B, Nebel A, Jager SU, Staehler P, Amarantos I, Boisguerin V, Staehler C, Beier M, Scheffler M, Büchler MW, Wischhusen J, Haeusler SF, Dietl J, Hofmann S, Lenhof HP, Schreiber S, Katus HA, Rottbauer W, Meder B, Hoheisel JD, Franke A, Meese E.

Nat Methods. 2011 Sep 4;8(10):841-3. doi: 10.1038/nmeth.1682.

PMID:
21892151
16.

Plasma miRNA as biomarkers for assessment of total-body radiation exposure dosimetry.

Cui W, Ma J, Wang Y, Biswal S.

PLoS One. 2011;6(8):e22988. doi: 10.1371/journal.pone.0022988. Epub 2011 Aug 17.

17.

Diagnostic and prognostic impact of six circulating microRNAs in acute coronary syndrome.

Widera C, Gupta SK, Lorenzen JM, Bang C, Bauersachs J, Bethmann K, Kempf T, Wollert KC, Thum T.

J Mol Cell Cardiol. 2011 Nov;51(5):872-5. doi: 10.1016/j.yjmcc.2011.07.011. Epub 2011 Jul 23.

PMID:
21806992
18.

Expression and rhythmic modulation of circulating microRNAs targeting the clock gene Bmal1 in mice.

Shende VR, Goldrick MM, Ramani S, Earnest DJ.

PLoS One. 2011;6(7):e22586. doi: 10.1371/journal.pone.0022586. Epub 2011 Jul 22.

19.

MicroRNA Expression Profile in CAD Patients and the Impact of ACEI/ARB.

Weber M, Baker MB, Patel RS, Quyyumi AA, Bao G, Searles CD.

Cardiol Res Pract. 2011;2011:532915. doi: 10.4061/2011/532915. Epub 2011 Jul 7.

20.

A serum circulating miRNA diagnostic test to identify asymptomatic high-risk individuals with early stage lung cancer.

Bianchi F, Nicassio F, Marzi M, Belloni E, Dall'olio V, Bernard L, Pelosi G, Maisonneuve P, Veronesi G, Di Fiore PP.

EMBO Mol Med. 2011 Aug;3(8):495-503. doi: 10.1002/emmm.201100154. Epub 2011 Jul 11.

Supplemental Content

Support Center